Germline mutations in BRCA1 confer a cumulative breast and ovarian cancer risk by age 80 of 72% and 44%, respectively, while BRCA2 mutations confer a 69% and 17% increased risk of breast and ovarian cancer by this age, respectively [4]. This evidence concerns the gene BRCA2 and ovarian carcinoma.